Daily Archives: September 7, 2022

The Lancet Series | Acute Respiratory Distress Syndrome 2022.

7 Sep, 2022 | 12:37h | UTC

Homepage: Acute Respiratory Distress Syndrome 2022 – The Lancet

Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes

Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management

Opportunities for improved clinical trial designs in acute respiratory distress syndrome

Addressing the inequity of acute respiratory distress syndrome

 

---

Stroke–heart syndrome: recent advances and challenges.

7 Sep, 2022 | 12:35h | UTC

Stroke–Heart Syndrome: Recent Advances and Challenges – Journal of the American Heart Association

 

Commentary on Twitter

Proud to share our updated review about the stroke-heart syndrome. Read more about recent advances on how brain ischemia can trigger cardiac events. https://t.co/ywJs2JbZht Many thanks to @SposatoL, @JohannesBacks and @Dr_No_Charite for your contribution! #brainheart #strokeheart pic.twitter.com/3IV9LU7fJN

— Jan Scheitz ?⚡️❤️ (@Jan_FriSch) September 3, 2022

Under a Creative Commons Attribution‐Non Commercial‐No Derivs License

 

---

Opinion | Tranexamic acid for safer surgery: the time is now.

7 Sep, 2022 | 12:37h | UTC

Tranexamic acid for safer surgery: the time is now – British Journal of Surgery

Related:

#ACC22 – RCT: Tranexamic acid reduces the risk of bleeding in patients undergoing noncardiac surgery.

Update on applications and limitations of perioperative tranexamic acid.

RCT | Effect of high- vs. low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery.

Safety of tranexamic acid in hip and knee arthroplasty in high-risk patients – this large observational study did not show an increased risk for venous thromboembolism, myocardial infarction, seizures, ischemic strokes, or transient ischemic attacks, irrespective of patient high-risk status at baseline

M-A: Intravenous tranexamic acid in surgical patients is not associated with increased risk of thromboembolic events and mortality

 

---

Patent ductus arteriosus: a contemporary perspective for the pediatric and adult cardiac care provider.

7 Sep, 2022 | 12:34h | UTC

Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider – Journal of the American Heart Association

 

---

Cohort Study | Children conceived via assisted reproductive technologies are at increased risk of childhood cancers.

7 Sep, 2022 | 12:32h | UTC

Assisted Reproductive Technology and Risk of Childhood Cancers – JAMA Network Open

Invited Commentary: Fertility Treatment and Childhood Cancer Risk – JAMA Network Open

 

Commentary on Twitter

Children born of assisted reproductive technology (ART) conception was associated with an increased risk of overall childhood cancers compared with those conceived naturally and those with subfertility and non-ART conception. #OpenAccess #Research https://t.co/HylUVE4gFg

— JAMA Network Open (@JAMANetworkOpen) August 31, 2022

 

---

Review | Diagnosis and treatment of myelodysplastic syndromes.

7 Sep, 2022 | 12:33h | UTC

Diagnosis and Treatment of Myelodysplastic Syndromes: A Review – JAMA (free for a limited period)

Audio Clinical Review: Diagnosis and Management of Myelodysplastic Syndromes – JAMA

 

---

Cohort Study | Fertility preservation procedures appear to be safe at the time of breast cancer diagnosis.

7 Sep, 2022 | 12:31h | UTC

Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis – JAMA Oncology

News Release: Fertility preservation measures do not appear to increase the risk of breast cancer recurrence – Karolinska Institutet

Commentary: Fertility Preservation Measures Do Not Appear to Increase the Risk of Breast Cancer Recurrence – The ASCO Post

 

---

Predictive role of atrial fibrillation in cognitive decline: a systematic review and meta-analysis of 2.8 million individuals.

7 Sep, 2022 | 12:30h | UTC

Predictive role of atrial fibrillation in cognitive decline: a systematic review and meta-analysis of 2.8 million individuals – EP Europace

 

Commentary on Twitter (thread – click for more)

AF associated with ⬆️ risk of cognitive impairment ?
? HR 1.39 general ?
? HR 2.70 post-stroke ?@natale_md @TJaredBunch @Dr_Santangeli @JonPicciniSr @DrMarthaGulati @rafavidalperez @DhirajGuptaBHRS @SABOURETCardio @iamritu @Hragy @mmamas1973 @SeguraCardio @cpgale3 #afib pic.twitter.com/dZxkd7G1wc

— Raviele Antonio (@drraviele) January 21, 2022

Under a https://creativecommons.org/licenses/by/4.0/ license

 

---

RCT | Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes.

7 Sep, 2022 | 12:30h | UTC

Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study – The Lancet Endocrinology (link to abstract – $ for full-text)

Commentary: ‘Artificial Pancreas’ Best in Poorly Controlled Type 1 Diabetes – Medscape (free registration required)

 

Commentary on Twitter

New—Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 #diabetes (ADAPT): a randomised controlled study https://t.co/XrrmoDuQLy #T1D pic.twitter.com/GSLWA3xX7F

— The Lancet Diabetes & Endocrinology (@TheLancetEndo) September 2, 2022

 

---

Cohort Study | Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria.

7 Sep, 2022 | 12:29h | UTC

Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria – Journal of Clinical Oncology (link to abstract – $ for full-text)

 

Commentary from the author on Twitter (thread – click for more)

Super excited to share our multicenter study on clonal evolution in 1008 patients with AA/PNH followed for a median f-up of 9 yrs now out in @JCO_ASCO https://t.co/j9U2ZjYX0o

— Carmelo Gurnari (@CarmeloGurnari) September 2, 2022

 

---